Star Imaging IPO is a small and medium enterprise (SME) public offer worth ₹62.65 crore. It will be open for investors to apply from August 8 to August 12, 2025. Out of this, ₹48.85 crore is from new shares, and ₹13.80 crore is from existing shareholders selling their shares.
Each share has a face value of ₹10, and the price range is set between ₹135 to ₹142 per share. Retail investors must apply for at least 2 lots, with 1 lot containing 1,000 shares—so a minimum of 2,000 shares, costing around ₹2,84,000(Upper Price Band). The IPO is expected to list on the BSE SME platform on August 18, 2025.
Stay tuned for more updates on the Star Imaging SME IPO, including details about the company, its financials, live subscription status, allotment, listing date, and listing price.
📈 IPO Listing Details
| IPO Listing Date | 18th August 2025 |
| ISIN | |
| BSE Script Code | |
| Issue Price | ₹ |
| Listing Price | [₹0] |
| Listing Gain/Loss (%) | [+0%] |
📈 Listing Day Trading Information
| Price | BSE |
|---|---|
| Share Allotment Price(Issue Price) | 0 |
| Open | 0 |
| High | 0 |
| Low | 0 |
| VWAP | 0 |
| Close | 0 |
📊 IPO Details
| IPO Type | SME |
|---|---|
| IPO Method | Book Building |
| IPO Open Date | 8th August 2025 |
| IPO Close Date | 12th August 2025 |
| IPO Listing Date | 18th August 2025 |
| Price Band | ₹135 to ₹142 per share |
| Lot Size | 1000 Shares (Minimum Bids 2000 Shares) |
| Face Value | 10 |
| Issue Size | ₹62.65 Crores (approx.)* |
| Fresh Issue | ₹48.85 Crores (approx.)* |
| Offer for Sale (OFS) | ₹13.80 Crores (approx.)* |
| Listing Exchange | BSE (BSE is the designated stock exchange) |
🔔 IPO Timeline
⏳ Star Imaging IPO Subscription Status (Day-wise)
| Day | QIB | NII | RII | Employees | Total |
|---|---|---|---|---|---|
| Day 1 | |||||
| Day 2 | |||||
| Day 3 | x | x | x | x | x |
📋 Star Imaging IPO IPO reservation table
| Investor Category | Shares Offered | Shares Bid For | Times Subscribed |
|---|---|---|---|
| Anchor Investors | 0 | 0 | 1x |
| Market Maker Portion | 480000 | 480000 | 1x |
| Qualified Institutional Buyers (QIB) (Other than Anchor) | 0 | 0 | x |
| Non-Institutional Investors (NII) Big# | 0 | 0 | x |
| Non-Institutional Investors (NII) Small# | 0 | 0 | x |
| Retail Individual Investors (RII) | 0 | 0 | x |
| Employee Reserved category | 0 | 0 | x |
| Total | 0 | x |
📦 Star Imaging IPO Lot Size
Table is Prepared at the upper end of the price band (₹142).
| Application | Lot Size | No. of Shares | Amount |
|---|---|---|---|
| Individual (Min) | |||
| Individual (Max) | |||
| S-HNI (Min) | |||
| S-HNI (Max) | |||
| B-HNI (Min) |
👤👥 Promoter Shareholding Table (Pre & Post Issue)
| Shareholder | Pre-Issue Holding (%) | Post-Issue Holding (%) |
|---|---|---|
| Promoters | 100.00% | 71.92% |
| Others (Public / Investors) | - | 28.08% |
| Total | 100% | 100% |
🏢 Company Overview
Star Imaging and Path Lab Limited is a diagnostic chain offering radiology and pathology services.Headquartered in Bhopal, Madhya Pradesh.Operates a hub-and-spoke model with central diagnostic labs supported by collection centers.
Services include: MRI, CT Scan, Ultrasound, X-ray, Blood Tests, and various other diagnostic procedures.
As of March 31, 2025, the company had: 26 collection centres,18 diagnostic centres(Spread across cities like Bhopal, Indore, Itarsi, Betul, and Mandideep.)
Focuses on quality healthcare, using advanced equipment and technology.Holds accreditations from NABL (for pathology labs) and NABH (for radiology services).Revenue comes from walk-in customers, hospitals, corporates, and government contracts.
🎯 Objects of the Offer
- Working Capital Requirement.
- Repayment of borrowings.
- Funding the Capital Expenditure of Purchase of Medical Equipment.
- General corporate purposes.
₹ Financial Snapshot (As of and For the Fiscal Ended on)
| Particulars | 31-Mar-2025 | 31-Mar-2024 | 31-Mar-2023 |
|---|---|---|---|
| Revenue (₹ Cr) | 83.50 | 78.78 | 58.53 |
| Revenue (₹ Cr)(Including Other Income) | 83.79 | 79.97 | 58.68 |
| Profit After Tax (₹ Cr) | 15.96 | 12.45 | 0.58 |
| Profit After Tax Margin (%)(On Total Revenue) | 19.10% | 15.72% | .98% |
| Earnings per share (in ₹) | 11.80 | 9.20 | .43 |
| Total Assets (₹ Cr) | 98.16 | 81.64 | 61.23 |
| Total Borrowings (₹ Cr) | 32.73 | 30.64 | 26.56 |
| Net Worth (₹ Cr) | 47.15 | 31.35 | 18.93 |
| NAV per equity share (in ₹) | 34.86 | 23.16 | 14.02 |
📈 Key Performance Indicators
| Particulars | FY2024-25 | FY2023-24 | FY2022-23 |
|---|---|---|---|
| EBITDA (₹ Cr) | 28.60 | 22.34 | 5.81 |
| EBITDA Margin (%) | 34.25% | 28.46% | 9.95% |
| Return on Net Worth (%) | 40.63% | 49.16% | 3.07% |
| Return on Capital Employed (RoCE %) | 23.10% | 29.54% | 5.74% |
| Debt Equity Ratio | .69 | .98 | 1.40 |
| Operating Cash Flows(₹ Cr) | (6.03) | 18.34 | 5.72 |
⚔️ Comparison with Listed Competitors
| Company Name | Star Imaging and Path Lab Limited | Chandan Healthcare Ltd | Vijaya Diagnostic Centre Ltd | Metropolis Healthcare Ltd |
|---|---|---|---|---|
| Revenue from Operations (FY24-25, ₹ in Cr) ok | 83.50 | 230.12 | 681.39 | 1331.20 |
| Face Value (₹) | 10 | 10 | 1 | 2 |
| Return on Equity (ROE) (%) | 33.84% | 19.18% | 18.07% | 10.93% |
| EBITDA Margin (%) FY 25 | 34.25% | 17.96% | 40.10% | 40.09% |
| PAT Margin (%) | 19.10% | 10.22% | 21.10% | 10.93% |
| Debt/Equity | 0.69 | 0.39 | 0.40 | 0.01 |
Data is based on the latest available financials 2024-2025. and may differ from actual market movements.
🔍 Strengths & Risks
💪 Key Strengths
- Strong presence across Central Indian cities like Bhopal and Indore
- Offers both pathology and radiology services
- Wide range of diagnostic services under one roof
- Uses advanced equipment and IT systems
- Scalable model using hub-and-spoke setup
- NABL and NABH accreditations for quality assurance
⚠️ Key Risks
- High dependence on Madhya Pradesh region
- Business relies on promoters and key personnel
- Faces strong competition from national diagnostic chains
- Subject to strict healthcare regulations
- Heavy reliance on equipment and IT systems
- Revenue concentration from select clients or institutions
📞 Key Contacts for Star Imaging IPO
| Company Contact Star Imaging & Path Lab Ltd. 4B/4, Tilak Nagar, Near Sant Pura, Tilak Nagar West, New Delhi - 110018 📞 Phone: +91 9990019189 📧 Email: cs@starimaging.in 🌐 Website: www.starimaging.in | Registrar to the Issue Kfin Technologies Limited KFintech, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Gachibowli, Hyderabad, Telangana - 500 032 🌐 Website: https://kosmic.kfintech.com/ipostatus/ 📞 Phone: 040-67162222, 040-79611000 📧 Email: sipll.ipo@kfintech.com |
📘 Book Running Lead Managers (BRLMs)
| BRLM Full Name |
|---|
| Share India Capital Services Private Limited |
For full contact details including representatives, emails, and phone numbers, of BRLM's please refer to the Red Herring Prospectus (RHP).
📂Important IPO Documents
- 📄 Red Herring Prospectus (RHP)
- 📄 Draft Red Herring Prospectus (DRHP)
- 📄 Anchor Investors Allocation Report.
- 📄 Basis of Allotment(Published After allotment)
📖FAQ's
- ✅HDFC Bank Bonus Issue 2025: 5 Essential Things Every Shareholders Must Know
- ✅Medistep Healthcare IPO Date, Price, Important Details & Review 2025
- ✅Star Imaging IPO Date, Price, Important Details & Review 2025
- ✅Connplex Cinema IPO Date, Price, Important Details & Review 2025
- ✅All Time Plastics IPO
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments and consult their investment advisor before making any investment decisions. While we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.
Disclaimer: Upcomingipo is not responsible for any errors or omissions or for the results obtained from the use of such information. Any reliance you place on such information is therefore strictly at your own risk. User shall confirm the accuracy of the information before using of the same from the official website of respective authority in the respective subject at user end.